All News

Safer Medication Practices: Empowering patients and healthcare professionals

A number of tools are available to encourage and empower both patients and their caregivers and health care professionals (for example nurses, physicians, pharmacists) to take an active role in ensuring safer medication practices and medication use processes including prescription, preparation, dispensing, administration and monitoring.

 

  • "5 questions to ask" tool (adopted from ISMP Canada) is available here

The World Health Organisation also has useful resources available at the following links:

 

 

Tamoxifen & SSRI.SNRI Antidepressants: Potential for Significant Drug interaction

Tamoxifen, widely used to treat breast cancer,  is a prodrug that is extensively metabolised via Cytochrome P450 (CYP2D6) isoenzymes in the liver to active metabolites. Concomitant use of drugs that are potent or moderately potent inhibitors of the CYP2D6 enzyme should be avoided whenever possible. 

 IMSN Safety Alert on Tamoxifen & SSRI/SNRI Antidepressants: Potential for Significant Drug Interaction

Reducing harm from omitted & delayed Parkinsons Disease medication

Medicines management is crucial in the care of the patient with Parkinson’s Disease (PD) when they are admitted to hospital, either electively or in an emergency. Missed or delayed doses can impair patients’ swallow, increase their risk of aspiration, render them immobile and prone to falls and fractures, and at worst, progress to Neuroleptic Malignant Syndrome, which can lead to coma or death.

 IMSN Safety Alert on Reducing Harm from Omitted & Delayed Parkinson's Disease Medications in Hospital